Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FGFR inhibitor for use in the treatment of hypophosphatemic disorders

FGFR inhibitor for use in the treatment of hypophosphatemic disorders

US Patent 10028955 · Granted Jul 24, 2018

Estimated economic value: $14,720,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Combinations of FGFR4 inhibitors and bile acid sequestrants2022
Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta2021
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Pharmaceutical combinations2018
Imidazopyrrolidine derivatives and their use in the treatment of disease2018
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease2017
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the tre2017
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction2017
Pyrrolopyrrolone derivatives and their use as BET inhibitors2017
Substituted purinone compounds2016